ROG — ROGERS CORP
—
NYSE ·
Materials ·
Chemicals ·
CIK 84748 ·
Last close
$148.12
Market Cap
$2.65B
52W High
$169.00
52W Low
$75.14
ADV30
256,919
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 216,800,000 | 70,400,000 | 20,700,000 | 13,600,000 | 1,446,400,000 | 181,400,000 | 241,700,000 |
| Mar 2026 | 200,500,000 | 64,600,000 | 16,600,000 | 4,500,000 | 1,426,500,000 | 195,800,000 | 233,800,000 |
| Dec 2025 | 201,500,000 | 63,500,000 | 15,100,000 | 4,600,000 | 1,429,900,000 | 197,000,000 | 234,200,000 |
| Sep 2025 | 216,000,000 | 72,300,000 | 22,800,000 | 8,600,000 | 1,446,000,000 | 167,800,000 | 243,300,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$106,000,000
Investing CF
$-51,700,000
Financing CF
$-28,900,000
CapEx
$-23,200,000
Dividends Paid
—
Buybacks
$-52,400,000
EPS Diluted TTM
$1.75
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$1,137,400,000
Inventory
$130,000,000
Receivables
$181,000,000
ST Investments
$30,000,000
EBIT TTM
$59,900,000
Pretax Income TTM
$58,500,000
Interest Exp TTM
$1,400,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$834,800,000
EBITDA
$128,800,000
Free Cash Flow
$99,825,000
Enterprise Value
$2,259,344,128
Total Cash
$211,400,000
Total Debt
$28,500,000
Shares Out
17,868,335
Trailing EPS
$1.69
Book Value
$67.30
ROE
2.6%
ROA
3.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 810,800,000 | 52,100,000 | -61,800,000 | 1,429,900,000 | 234,200,000 | 1,195,700,000 | 101,200,000 |
| Dec 2024 | 830,100,000 | 49,100,000 | 26,100,000 | 1,481,100,000 | 229,500,000 | 1,251,600,000 | 127,100,000 |
| Dec 2023 | 908,400,000 | 69,100,000 | 56,600,000 | 1,517,200,000 | 258,200,000 | 1,259,000,000 | 131,400,000 |
| Dec 2022 | 971,200,000 | 67,000,000 | 116,600,000 | 1,646,200,000 | 473,700,000 | 1,172,500,000 | 129,500,000 |
TTM Snapshot
Revenues TTM
$820,800,000
NetIncome TTM
$-55,900,000
OpCashFlow TTM
—
Assets (Latest)
$1,426,500,000
Forward EPS
$4.45
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $140.00 · spot: $147.41 · call volume: 58 · put volume: 14
Expected Move to 2026-10-16:
±$7.05
(4.78%) —
implied range
$140.36 –
$154.46
· ATM straddle on $145.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FUL | FULLER H B CO | $2.72B | $50.44 | — |
| WDFC | WD 40 CO | $2.74B | $203.90 | — |
| COTY | COTY INC. | $2.46B | $2.79 | — |
| NGVT | Ingevity Corp | $2.45B | $71.41 | — |
| IOSP | INNOSPEC INC. | $2.41B | $97.69 | — |
News headlines (Yahoo Finance, 1h cache)
Rogers Targets $1.5B Sales by 2030 on AI Data Center, Battery Growth
2026-10-03 08:02 · Yahoo
Rogers Stock Surges 11% After Investor Day. Here’s Why
2026-10-01 02:00 · Yahoo
Rogers Corporation Provides 2030 Financial Targets at 2026 Investor Day
2026-09-30 20:05 · Yahoo
Rogers Corporation to Host Investor Day on September 30, 2026
2026-09-30 10:55 · Yahoo
Rogers (ROG) Stock Looks Overvalued After Its 73% Rise
2026-09-25 03:12 · Yahoo
FDA approves Roche’s Tecentriq in combination with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of a certain type of stage III colon cancer
2026-10-09 05:00 · Yahoo
Rogers Corp. (ROG) Moves 10.7% Higher: Will This Strength Last?
2026-10-01 10:01 · Yahoo
Roche presents new data at EURETINA, highlighting Vabysmo’s real-world effectiveness and safety across major retinal conditions
2026-10-01 06:00 · Yahoo
Roche’s giredestrant combination significantly improved progression-free survival in ER-positive advanced breast cancer in phase III evERA data published in The New England Journal of Medicine
2026-10-01 05:00 · Yahoo
Rogers (ROG) Shares Skyrocket, What You Need To Know
2026-09-30 22:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.